In approximately 85% of the HHT patients, mutations in the Endoglin (ENG) or Activin receptor-like kinase 1 (ACVRL1) gene are found, causing HHT type 1 and type 2, respectively [3,4]. The gene discussed is ENG; the disease is hereditary hemorrhagic telangiectasia.